Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion

By Riddell D.R.   Owen J.S.  

Thrombosis Research, Vol. 80, Iss. 6, 1995-12 ,pp. : 499-508

Elsevier

Access to resources Recommend Favorite

Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis

By Glenn J. R.   White A. E.   Johnson A. J.   Fox S. C.   Myers B.   Heptinstall S.  

Platelets, Vol. 19, Iss. 1, 2008-02 ,pp. : 59-69

Informa Healthcare

Access to resources Recommend Favorite

cAMP is an important messenger for ADP-induced platelet aggregation

By Weber Artur-Aron   Hohlfeld Thomas   Schror Karsten  

Platelets, Vol. 10, Iss. 4, 1999-07 ,pp. : 238-241

Informa Healthcare

Access to resources Recommend Favorite

Protective effect of three diallyl sulphides against glucose-induced erythrocyte and platelet oxidation, and ADP-induced platelet aggregation

By Chan K.-c.   Hsu C.-c.   Yin M.-c.  

Thrombosis Research, Vol. 108, Iss. 5, 2002-12 ,pp. : 317-322

Elsevier

Access to resources Recommend Favorite

Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3

By Storey Robert   Melissa Thornton S.   Lawrance Rachael   Husted Steen   Wickens Mark   Emanuelsson Håkan   Cannon Christopher   Heptinstall Stan   Armstrong Martin  

Platelets, Vol. 20, Iss. 5, 2009-08 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite